4//SEC Filing
Kelley Robert J. 4
Accession 0001209191-23-023993
CIK 0001584751other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:06 PM ET
Size
5.5 KB
Accession
0001209191-23-023993
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2023-04-07+500,000→ 500,000 totalExercise: $0.49Exp: 2033-04-07→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date of March 1, 2023 and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
Documents
Issuer
Talis Biomedical Corp
CIK 0001584751
Entity typeother
Related Parties
1- filerCIK 0001845542
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:06 PM ET
- Size
- 5.5 KB